JAKARTA - Kalgen Innolab will assist in the procurement of the Polymerase Chain Reaction (PCR) test to detect the corona virus or COVID-19 in Indonesia. The laboratory under the company PT Kalbe Farma Tbk is ready to test thousands of specimens taken from the monthly swab test.
"The PCR tests we currently provide are five thousand tests that we will carry out in the laboratory, Kalgen Innolab," said Head of Kalgen Innolab Sie Djohan in a press conference broadcast on the YouTube account of the National Disaster Prevention Agency (BNPB), Thursday, April 16.
This number, he said, will continue to increase when the automatic extraction equipment arrives in Jakarta, reaching a total of 8,000 in the future. So that it is hoped that more positive cases of COVID-19 can be revealed.
Djohan added that the PCR test would not take days, only 24 hours after the sample from the swab test was received.
In addition, there is no fee for carrying out the PCR test. However, people who want to carry out the test cannot come there. This is because this laboratory does not accept sampling. For samples from the swab test or taking fluid from the nasal cavity or throat, it must still be carried out at the referral hospital.
"As a laboratory for examining COVID-19, Kalgen Innolab does not serve individual patients, but only accepts samples from hospitals, especially COVID-19 referral hospitals," he said.
Apart from providing PCR test assistance in his laboratory, Djohan, who is also the Director of PT Kalbe Farma Tbk, said that there was another assistance amounting to Rp25 billion. They have prepared this fund to help deal with COVID-19.
Among them are providing 10 thousand rapid test tools to detect the spread of the virus through the telemedicine application, namely KlikDokter. If later the patient's test results test positive, they will then be referred to the hospital for further tests and treatment.
Then, Djohan said, there were 20 thousand personal protective equipment (PPE) that would be donated to hospitals in Jakarta and various areas, as well as one million masks for the community. "Vitamins and our own medicinal products will also be donated to hospitals in various regions," he said.
Previously, the government was increasingly looking for or tracing contact tracing from positive patients by examining 10,000 people per day using the polymerase chain reaction (PCR) method.
According to the spokesman for the handling of COVID-19 Achmad Yurianto (Yuri), this was done by activating dozens of laboratories scattered throughout Indonesia. Thus, the capacity and inspection will be greater and more efficient.
"We must aim for the target of conducting 10,000 realtime PCR tests per day, by activating 78 laboratories from the previous 32 laboratories," said Yuri at Graha BNPB, Jakarta, Wednesday, April 15.
Laboratory activation is supported by the procurement of tools or reagents and human resources from volunteers. Currently, tools or reagents have been imported in large quantities and will soon be distributed to all laboratories for specimen examination.
"We have brought in another 150 thousand PCR reagents, and this will be distributed immediately to laboratories that have become networks for testing COVID-19," said Yuri.
Based on available data, around 36,000 specimens have been examined by the PCR method. The samples came from hospitals that treat COVID-19 patients throughout Indonesia.
"This sample comes from 196 regencies and cities throughout Indonesia that are currently treating COVID-19 patients. There are more than 800 private hospitals owned by the central government, regional government owned by BUMN, TNI and Polri, which have provided COVID-19 pandemic care services -19, "said Yuri.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
